EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Five New Cantharidin Derivatives from the Insect Mylabris cichorii L. and Their Potential against Kidney Fibrosis In Vitro

Ke-Ming Li, Ji-Jun Li, Li Wan iD, Yong-Xian Cheng iD

Molecules · 2023

DOI: 10.3390/molecules28062822 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Ke-Ming Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China. Hauptthemen laut MEDLINE: Cantharidin, Coleoptera. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shenzhen Science and Technology Program, Shenzhen Fundamental Research Program, National Science Fund for Distinguished Young Scholars.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Five new monoterpenoids including three 1-hydroxymethyl-2-methyl cantharimide-type derivatives (1, 2, and 5) and two 1,2-dimethyl cantharimide-type derivatives (3 and 4), together with three known compounds (6–8) were isolated from the insect Mylabris cichorii Linnaeus. The structures of these new compounds, including their absolute configurations, were characterized by detailed analysis of NMR, chemical derivatization, and quantum chemical ECD calculations. All of the compounds were tested for their biological activity against kidney fibrosis. The results revealed that compounds 2, 4, and 7 could inhibit kidney fibrosis in vitro at 40 μM by inhibiting the expression of fibronectin and collagen I in TGF-β1-induced NRK-52e cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CantharidinColeopteraAnimalsFibrosisMagnetic Resonance SpectroscopyKidneyTransforming Growth Factor beta1

Stichwörter der Autor:innen

Mylabris cichorii linnaeuscantharidin derivativesinsectskidney fibrosis

Substanzen

CantharidinTransforming Growth Factor beta1

Autor:innen und Institutionen

  • School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
  • Institute for Inheritance-Based Innovation of Chinese Medicine, Medical School of Pharmaceutical Sciences, Shenzhen University, Shenzhen 518060, China.

ORCID-Profile: Li Wan, Yong-Xian Cheng

Förderung

  • Shenzhen Science and Technology Program
  • Shenzhen Fundamental Research Program
  • National Science Fund for Distinguished Young Scholars

Zitieren

APA

Li, K. M., Li, J. J., Wan, L., & Cheng, Y. X. (2023). Five New Cantharidin Derivatives from the Insect Mylabris cichorii L. and Their Potential against Kidney Fibrosis In Vitro. Molecules. https://doi.org/10.3390/molecules28062822

Vancouver

Li KM, Li JJ, Wan L, Cheng YX. Five New Cantharidin Derivatives from the Insect Mylabris cichorii L. and Their Potential against Kidney Fibrosis In Vitro. Molecules. 2023. doi:10.3390/molecules28062822

BibTeX
@article{Li2023,
  author = {Li, Ke-Ming and Li, Ji-Jun and Wan, Li and Cheng, Yong-Xian},
  title = {Five New Cantharidin Derivatives from the Insect Mylabris cichorii L. and Their Potential against Kidney Fibrosis In Vitro},
  journal = {Molecules},
  year = {2023},
  doi = {10.3390/molecules28062822}
}
Kostenlos starten →